Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
about
Targeted Therapies in Adult B-Cell MalignanciesInhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.Differential effects of lenalidomide during plasma cell differentiationDNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.
P2860
Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Residual malignant and normal ...... ic window in Multiple Myeloma?
@ast
Residual malignant and normal ...... ic window in Multiple Myeloma?
@en
type
label
Residual malignant and normal ...... ic window in Multiple Myeloma?
@ast
Residual malignant and normal ...... ic window in Multiple Myeloma?
@en
prefLabel
Residual malignant and normal ...... ic window in Multiple Myeloma?
@ast
Residual malignant and normal ...... ic window in Multiple Myeloma?
@en
P2093
P2860
P356
P1433
P1476
Residual malignant and normal ...... ic window in Multiple Myeloma?
@en
P2093
Anouk Caraux
Bernard Klein
Gaëlle Olivier
Guilhem Requirand
Guillaume Cartron
Jean-François Rossi
Jean-Luc Veyrune
Jérôme Moreaux
Laure Vincent
Philippe Quittet
P2860
P304
P356
10.18632/ONCOTARGET.650
P407
P577
2012-11-01T00:00:00Z